Диссертация (1140221), страница 26
Текст из файла (страница 26)
et al. Homocysteine, MTHFR 677C->Tpolymorphism, and risk of ischemic stroke: results of a meta-analysis // Neurology.2002 Aug 27;59(4):529-36.114. Kemmeren J.M., Algra A., Grobbee D.E. Third generation oral contraceptivesand risk of venous thrombosis: meta-analysis // BMJ 2001;323:131-4.115. Kluft C., Endrikat J., Mulder S.M. et al. A prospective study on the effects onhemostasis of two oral contraceptives containing drospirenone in combination witheither 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and30 microg ethinyl estradiol // Contraception.
2006;73:4:336-343.116.Konecny F. Inherited trombophilic states and pulmonary embolism // J Res MedSci. 2009 Jan-Feb; 14(1): 43–56.117. Koniari I., Siminelakis S.N., Baikoussis N.G. et al. Antiphospholipid syndrome;its implication in cardiovascular diseases: a review // J Cardiothorac Surg. 2010Nov 3;5:101118. Kwaan H.C., Nabhan C. Hereditary and acquired defects in the fibrinolyticsystem associated with thrombosis // Hematol Oncol Clin North Am.
2003Feb;17(1):103-14.119. Lalouschek W., Schillinger M., Hsieh K. et al. Matched case-control study onfactor V Leiden and the prothrombin G20210A mutation in patients with ischemicstroke/transient ischemic attack up to the age of 60 years // Stroke. 2005Jul;36(7):1405-9.120. Lane D.A., Mannucci P.M., Bauer K.A. et al. Interited thrombophilia: part 2.
//Thromb Haemost 1996; 76: 824.163121. Lepercq J., Conard J., Borel-Derlon A. et al. Venous thromboembolism duringpregnancy: a retrospective study of enoxaparin safety in 624 pregnancies // BJOG.2001 Nov;108(11):1134-40.122. Lidegaard O, Edström B, Kreiner S. Oral contraceptives and venousthromboembolism. A case-control study // Contraception 1998;57:291-301123. Lidegaard O, Edström B, Kreiner S. Oral contraceptives and venousthromboembolism: a five-year national case-control study // Contraception2002;65:187-96124.Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N.
- Thromboticstroke and myocardial infarction with hormonal contraception. // The New Englandjournal of medicine 2012; 366:2257-66.125. Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E. - Riskof venous thromboembolism from use of oral contraceptives containing differentprogestogens and oestrogen doses: Danish cohort study, 2001-9 // BMJ2011;343:d6423.126.
Lowe GD. Common risk factors for both arterial and venous thrombosis //British Journal Haematol. 2008; 140:5:488-495.127. Macìas G, Merki-Feld GS, Parke S, Mellinger U, Serrani M. Effects of acombined oral contraceptive containing oestradiol valerate/dienogest on hormonewithdrawal-associated symptoms: results from the multicentre, randomised,double-blind, active-controlled HARMONY II study // Journal Obstet Gynaecol.2013; 33:6:591-596128. Mak A., Cheung M.W., Cheak A.A., Ho R.C. Combination of heparin andaspirin is superior to aspirin alone in enhancing live births in patients with recurrentpregnancy loss and positive anti-phospholipid antibodies: a meta-analysis ofrandomized controlled trials and meta-regression // Rheumatology.
2010Feb;49(2):281-8.129. Martinelli I., Anthonie W., Middeldorp S., Levi M. Recurrent venousthromboembolism and abnormal uterine bleeding with anticoagulant and hormonetherapy use // Blood. 2016 Mar 17; 127(11): 1417–1425.164130. Martinelli I., Battaglioli T., Burgo I et al. Oral contraceptive use, thrombophiliaand their interaction in young women with ischemic stroke // Haematologica. 2006Jun;91(6):844-7.131. Martinelli I., Taioli E., Bucciarelli P. Interaction Between the G20210AMutation of the Prothrombin Gene and Oral Contraceptive Use in Deep VeinThrombosis // Arterioscler Thromb Vasc Biol.
1999 Mar;19(3):700-3132. Meltzer M.E., Doggen C.J., de Groot PG et al. The impact of the fibrinolyticsystem on the risk of venous and arterial thrombosis // Semin Thromb Hemost. 2009Jul;35(5):468-77.133. Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G,et al. Effects on coagulation of levonorgestrel- and desogestrel-containing low doseoral contraceptives: a cross-over study // Thromb Haemost 2000;84:4-8.134. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR,Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-basedstudy // J Thromb Haemost 2007;5:692-9.135.Nan Y., Li H.
MTHFR genetic polymorphism increases the risk of pretermdelivery // Int J Clin Exp Pathol. 2015 Jun 1;8(6):7397-402.136. Nappi R.E, Serrani M., Jensen J.T. Non-contraceptive benefits of the estradiolvalerate/dienogest combined oral contraceptive: a review of the literature // IntJournal Womens Health. 2014; 6: 711-718.137. Nørgård B., Puhó E., Czeizel A.E. et al.
Aspirin use during early pregnancy andthe risk of congenital abnormalities: a population-based case-control study // Am JObstet Gynecol. 2005 Mar;192(3):922-3.138. Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R. Effects of anew oral contraceptive containing an antimineralocorticoid progestogen,drospirenone, on the renin-aldosterone system, body weight, blood pressure,glucose tolerance, and lipid metabolism // J Clin Endocrinol Metab 1995;80:181621.139. Pabinger I. Thrombophilia and its impact on pregnancy // Thromb Res. 2009;123Suppl 3:S16-21.165140.
Parkin L, Skegg DC, Wilson M, Herbison GP, Paul C. Oral contraceptives andfatal pulmonary embolism // Lancet 2000;355:2133-4141.Pasquier E, de Saint Martin L, Bohec C. Enoxaparin for prevention ofunexplained recurrent miscarriage: a multicenter randomized double-blind placebocontrolled trial // Blood. 2015;125(14):2200–2205142. Patnaik M.M., Moll S. Inherited antithrombin deficiency: a review //Haemophilia. 2008 Nov;14(6):1229-39.143.
Pezzini A., Inherited thrombophilia and stratification of ischaemic stroke riskamong users of oral contraceptives / A. Pezzini, M. Grassi, L. Iacoviello et al. // JNeurol Neurosusg Psychiatry, 2007. — Vol. 78. — N 3. — P. 271-216.144.Pierre Gourdy, Anne Bachelot, Sophie Catteau-Jonard – Hormonalcontraception in women at risk of vascular and metabolic disorders: Guidelines ofthe French Society of Endocrinology // Annales d’Endocrinologie 73 (2012) 469487145.Pierre Suchon, Fadi Al Frouh, Agathe Henneuse – Risk factors for venousthromboembolism in women under combined oral contraceptive // Thrombosis andHaemostasis 2016, 115: 135-142146. Ravina E.
The Evolution of Drug Discovery: From Traditional Medicines toModern Drugs // John Wiley & Sons. 2011 pp. 193–. ISBN 978-3-527-32669-3.147. Righini M., Perrier A., De Moerloose P. et al. D-Dimer for venousthromboembolism diagnosis: 20 years later // J Thromb Haemost. 2008Jul;6(7):1059-71.148. Ros H.S, Lichtenstein P., Bellocco R. et al. Pulmonary embolism and stroke inrelation to pregnancy: how can high-risk women be identified? // Am J ObstetGynecol. 2002 Feb;186(2):198-203.149.
Rosing J, Tans G, Nicolaes GA. et al. Oral contraceptives and venousthrombosis: different sensitivities to activated protein C in women using secondand third-generation oral contraceptives // British Journal Haematol. 1997;97:1:233-238.166150.Rott H., A. Krümpel, G.
Kappert - Contraception and thrombophilia //Hämostaseologie, 2009 (Vol. 29): Issue 2, p. 193-196151.Sarah H. Wakelin - Systemic Drug Treatment in Dermatology: A Handbook.CRC Press. 2002 - p. 32. ISBN 978-1-84076-013-2.152.Sarah H., O'Brien -Contraception-Related Venous Thromboembolism inAdolescents // Semin Thromb Hemost 2014; 40(01): 066-071153. Seeger J.D., Loughlin J., Eng P.M., Clifford C.R., Cutone J., Walker AM. - Riskof thromboembolism in women taking ethinylestradiol/drospirenone and other oralcontraceptives // Obstet Gynecol. 2007 Sep;110(3):587-93.154. Segal J.B., Brotman D.J., Necochea A.J. et al. Predictive value of factor VLeiden and prothrombin G20210A in adults with venous thromboembolism and infamily members of those with a mutation: a systematic review // JAMA. 2009 Jun17;301(23):2472-85.155.
Sokol V., Ivanišević M., Herman M., Đelmiš J. The role of low molecular weightheparin in women with hereditary thrombophilia for good perinatal outcome // ActaClin Croat. 2016 Jun;55(2):309-15.156.Spyros A. Liatsikos, Panagiotis Tsikouras, Bachar Manav - Inheritedthrombophilia and reproductive disorders // J Turk German Gynecol Assoc 2016;17: 45-50157. Sun L, Lv H, Wei W, Zhang D, Guan Y.
Angiotensin-converting enzyme D/Iand plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associatedwith increased risk of spontaneous abortions in polycystic ovarian syndrome. //158. Tans G, Curvers J, Middeldorp S, Thomassen MCLGD, Meijers JC, Prins MH,et al. A randomized cross-over study on the effects of levonorgestrel- anddesogestrel-containing oral contraceptives on the anticoagulant pathways // ThrombHaemost 2000; 84:15-21159. Tans G, Vlieg H.
A., Thomassen MCLGD, Curvers J, Bertina RM, Rosing J, etal. Activated protein C resistance determined with a thrombin generation-based testpredicts for venous thrombosis in men and women // Br J Haematol 2003;122:46570167160. Tepper N.K., Marchbanks P., Curtis K. Superficial venous disease and combinedhormonal contraceptives: a systematic review // Contraception.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
